These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 6214894)

  • 1. [Learning disabilities and genetics with particular reference to Down's syndrome].
    Schmid W
    Wien Klin Wochenschr; 1982 Jun; 94(12):317-21. PubMed ID: 6214894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics, amniocentesis, and abortion.
    Hirschhorn K
    Mt Sinai J Med; 1984; 51(1):15-7. PubMed ID: 6608672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-benefit analysis of prenatal screening for trisomy 21 through analysis of HCG in maternal blood].
    Seror V; Moatti JP; Muller F; Le Galès C; Boué A
    Rev Epidemiol Sante Publique; 1993; 41(1):3-15. PubMed ID: 8465062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of academic attainments of young people with Down's syndrome.
    Turner S; Alborz A; Gayle V
    J Intellect Disabil Res; 2008 May; 52(Pt 5):380-92. PubMed ID: 18205756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-natal counselling and diagnosis in Down's syndrome.
    Papp Z
    Med Gynaecol Androl Sociol; 1973; 7(4):10-5. PubMed ID: 12156379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological consequences for parents of false negative results on prenatal screening for Down's syndrome: retrospective interview study.
    Hall S; Bobrow M; Marteau TM
    BMJ; 2000 Feb; 320(7232):407-12. PubMed ID: 10669444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prospects for "preventing" Down's syndrome in an English region.
    Forster DP
    Rev Epidemiol Sante Publique; 1980 Dec; 28(4):423-30. PubMed ID: 6452660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Economic analysis of the dissemination of a medical innovation: prenatal diagnosis by early amniocentesis as an example. Part 2. Facilitating decision making in public health for optimal dissemination of an innovation].
    Gardent H; Fardeau M; Lanöe JL; Kerleau M
    Rev Epidemiol Sante Publique; 1984; 32(2):97-106. PubMed ID: 6237394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences of women who decided to continue the pregnancy after diagnosis of Down's syndrome].
    Tijmstra TJ; Bosboom GJ; Bouman K
    Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2104-7. PubMed ID: 11103672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understandings of Down's syndrome: a Q methodological investigation.
    Bryant LD; Green JM; Hewison J
    Soc Sci Med; 2006 Sep; 63(5):1188-200. PubMed ID: 16644080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. People with Down's sindrome: adolescence and the journey towards adulthood.
    La Grutta S; Lo Baido R; Calì A; Sarno I; Trombini E; Roccella M
    Minerva Pediatr; 2009 Jun; 61(3):305-21. PubMed ID: 19461574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
    Spencer K; Aitken DA; Macri JN; Buchanan PD
    Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.
    Jørgensen FS
    Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264
    [No Abstract]   [Full Text] [Related]  

  • 19. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.